The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Artificial Pancreas Device System Market Progress Between 2026 And 2030?
The artificial pancreas device system market size has witnessed rapid expansion in recent years. It is anticipated to increase from $2.06 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.9%. The growth observed in the past can be credited to the rising incidence of diabetes, the swift adoption of insulin pump technologies, the expanded utilization of continuous glucose monitoring, enhancements in medical sensor accuracy, and increasing awareness regarding automated diabetes management.
The market size for artificial pancreas device systems is anticipated to experience significant expansion over the next few years. It is forecast to achieve a valuation of $3.92 billion by 2030, registering a compound annual growth rate (CAGR) of 13.7%. This projected growth during the forecast period can be ascribed to several driving factors, such as the increasing demand for fully automated glucose regulation, escalating investments in digital diabetes care, the broader implementation of remote patient monitoring, an intensifying focus on personalized insulin therapy, and greater regulatory endorsement for advanced diabetes devices. Prominent trends expected within this period include the rising adoption of closed-loop glucose control systems, the growing integration of continuous glucose monitoring (CGM) with insulin pumps, an expanded utilization of predictive algorithms for insulin delivery, the proliferation of wearable diabetes management devices, and an augmented focus on patient-centric automation.
Access Your Free Sample Report For In-Depth Market Analysis:
What Leading Drivers Are Supporting The Artificial Pancreas Device System Market Expansion?
The rising incidence of pancreatic cancer is projected to propel the expansion of the artificial pancreas device system market in the future. Pancreatic cancer refers to a malignant tumor that originates in the pancreas, an organ situated behind the stomach. This condition is influenced by a combination of lifestyle, genetic, medical, and environmental elements, in addition to genetic mutations causing hereditary pancreatitis, which can lead to persistent inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily designed to aid individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate quantity of insulin. For instance, in March 2024, Cancer Australia, a government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, an increase from the 3,751 cases reported over the past five years. Therefore, the growing prevalence of pancreatic cancer is a significant factor driving the growth of the artificial pancreas device system market.
Which Segments Define The Artificial Pancreas Device System Market Segment Structure?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
What Emerging Trends Are Seen In The Artificial Pancreas Device System Market?
Leading companies within the artificial pancreas device system market are actively developing automated insulin delivery systems. These innovations aim to significantly improve diabetes management by continuously monitoring blood glucose levels and administering the precise amount of insulin needed. The primary goal of automated insulin delivery systems is to mimic the natural function of a healthy pancreas, thereby reducing the constant demand for blood sugar tracking and manual insulin injections for individuals with diabetes. For example, in May 2023, Beta Bionics, a US-based medical equipment manufacturing company, secured FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This particular artificial pancreas system is engineered to independently determine and deliver appropriate insulin doses to regulate blood glucose levels. Operating as a closed-loop system, it automatically modifies insulin delivery based on the user’s glucose levels, which are measured by a connected continuous glucose monitor (CGM). The system only requires the user’s body weight and an estimated meal size to automatically adjust insulin delivery.
Who Are The Established Players Within The Artificial Pancreas Device System Market?
Major companies operating in the artificial pancreas device system market are Medtronic plc, Abbott Laboratories, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Roche Diabetes Care, Ypsomed, SOOIL Development, Beta Bionics Inc., Bigfoot Biomedical Inc., Diabeloop SA, Inreda Diabetic B.V., Defymed SAS, DreaMed Diabetes Ltd., Medtrum Technologies Inc., EOFlow Co. Ltd., Cellnovo, Pancreum Inc., Admetsys Corporation, GlucoModicum, MicroTech Medical
Get The Full Artificial Pancreas Device System Market Report:
Which Region Holds The Highest Market Share In The Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Pancreas Device System Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2026, By The Business Research Company
Hepato Pancreatico Biliary Hpb Surgeries Surgical Devices Market Report 2026
Diabetes Care Devices Market 2026
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market
Gastrointestinal Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model